Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) EBT Margin (2020 - 2025)

Historic EBT Margin for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to 32.62%.

  • Treace Medical Concepts' EBT Margin rose 14900.0% to 32.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 23.1%, marking a year-over-year increase of 73700.0%. This contributed to the annual value of 26.78% for FY2024, which is 1300.0% down from last year.
  • As of Q3 2025, Treace Medical Concepts' EBT Margin stood at 32.62%, which was up 14900.0% from 36.97% recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' EBT Margin registered a high of 0.9% during Q4 2024, and its lowest value of 47.95% during Q2 2024.
  • Over the past 5 years, Treace Medical Concepts' median EBT Margin value was 31.12% (recorded in 2022), while the average stood at 28.43%.
  • As far as peak fluctuations go, Treace Medical Concepts' EBT Margin plummeted by -304500bps in 2021, and later skyrocketed by 130600bps in 2023.
  • Quarter analysis of 5 years shows Treace Medical Concepts' EBT Margin stood at 19.8% in 2021, then surged by 59bps to 8.15% in 2022, then decreased by -26bps to 10.25% in 2023, then skyrocketed by 91bps to 0.9% in 2024, then plummeted by -3521bps to 32.62% in 2025.
  • Its last three reported values are 32.62% in Q3 2025, 36.97% for Q2 2025, and 30.53% during Q1 2025.